Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 57 min ago
Peer-reviewedCC BY 4.0Frontiers in Endocrinology

Association between serum estradiol levels on the hCG trigger day and euploid blastocyst rate in preimplantation genetic testing cycles: a retrospective cohort study

  1. 1Center for Reproductive Medicine, Women and Children’s Hospital of Chongqing Medical University
  2. 2Center for Reproductive Medicine, Chongqing Health Center for Women and Children

Abstract

Background: While serum estradiol (E2) predicts ovarian response and endometrial receptivity, its role in embryonic development remains unclear. This study assessed the association between E2 levels on the day of human chorionic gonadotropin (hCG) trigger and the euploid blastocyst rate (EBR) in preimplantation genetic testing (PGT) cycles.

Methods: This retrospective study included 3,082 couples who underwent PGT between 2017 and 2022, comprising 18,036 oocytes and 5,009 blastocysts screened using next-generation sequencing. Oocytes were stratified into tertiles based on serum E2 levels on the hCG trigger day: Group 1 (<3149 pg/mL), Group 2 (3149–4725.66 pg/mL), and Group 3 (≥4725.67 pg/mL). Associations between serum E2 levels and both blastocyst formation rate (BFR) and EBR were assessed using univariate stratified analyses and multivariable generalized estimating equation (GEE) models (crude, Model I, Model II) accounting for patient-level clustering. Restricted cubic spline (RCS) analysis with three knots, collinearity diagnostics (variance inflation factor, VIF), and formal E2 × total gonadotropin (Gn) dose interaction tests were additionally performed.

Results: Univariate stratified analyses showed subgroup-specific patterns: higher E2 generally correlated with lower blastocyst formation rate (BFR) yet higher EBR. In fully adjusted GEE Model II, E2 was not associated with BFR (Group3 vs Group1: aOR 1.050, 95%CI 0.910–1.212, P = 0.502; P-trend=0.653), while high E2 was associated with higher EBR (aOR 1.295, 95%CI 1.028–1.631, P = 0.028; P-trend=0.047). RCS revealed no significant overall E2–BFR (P-overall=0.107; P-nonlinearity=0.055) or E2–EBR associations (P-overall=0.100; P-nonlinearity=0.119), although the EBR curve showed an upward high-E2 trend consistent with tertile results. No multicollinearity was detected (all VIF <6, range 1.137–5.399), and no significant E2–Gn interactions existed (all P>0.05). Sensitivity analysis excluding oocyte number yielded consistent EBR estimates (aOR 1.232, 95%CI 1.006–1.508, P = 0.044).

Conclusion: In PGT cycles, elevated hCG-trigger-day E2 was not associated with BFR but was modestly associated with higher EBR. These observational findings require prospective validation and should not be interpreted as evidence of a causal or protective effect of E2 on embryonic chromosomal integrity.

Related

  1. Trigger-day progesterone-to-mature-oocyte ratio, cycle-level blastocyst yield, and recorded embryo-transfer outcomes: a retrospective cohort study
    Yidong Wei, Yu Xu, Nuanfang Wei +4
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefDOAJ
  2. Predicting blastocyst viability: the role of post-vitrification re-expansion speed and its correlation with artificial collapse and preimplantation genetic testing.
    Adva Aizer, Shay Kaplan, Meirav Noach-Hirsh +5
    Journal of ovarian researchPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
  3. Preimplantation genetic testing for aneuploidy (PGT-A) vs. morphology-based blastocyst selection for transfer: cost-effectiveness analysis within Israel's publicly funded IVF system.
    Einat Zivi, Moshe Leshno, Ariel Hammerman +1
    Israel journal of health policy researchPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCPMC
  4. Effect of the 'Ready-to-Use Vitrification and Warming Kit' on Pregnancy Rates Following Vitrification-warmed Blastocyst Transfer: A Retrospective Study.
    Yamato Mizobe, Yuji Orita, Kazuhiro Takeuchi
    Journal of human reproductive sciencesPeer-reviewedCC BY-NC-SAFull textEpidemiology & public healthEurope PMC
  5. Genetic and non-genetic contributions to early spontaneous miscarriage in women with PCOS undergoing PGT-A and single euploid blastocyst transfer: a retrospective cohort study
    Zhiqin Bu, Xiaofei Ge, Jing Sun +1
    BMC Pregnancy and ChildbirthPeer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsPMC
BibTeX
@article{shuai2026association,
  title = {{Association between serum estradiol levels on the hCG trigger day and euploid blastocyst rate in preimplantation genetic testing cycles: a retrospective cohort study}},
  author = {Jun Shuai and Weiwei Liu and Xinyue Sun and Qi Zhang and Hong Ye and Huali Deng and Guoning Huang},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  month = oct,
  doi = {10.3389/fendo.2026.1935196},
  url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1935196/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Association between serum estradiol levels on the hCG trigger day and euploid blastocyst rate in preimplantation genetic testing cycles: a retrospective cohort study
AU  - Jun Shuai
AU  - Weiwei Liu
AU  - Xinyue Sun
AU  - Qi Zhang
AU  - Hong Ye
AU  - Huali Deng
AU  - Guoning Huang
PY  - 2026
DA  - 2026/10/14
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.1935196
UR  - https://www.frontiersin.org/articles/10.3389/fendo.2026.1935196/full
AB  - Background: While serum estradiol (E2) predicts ovarian response and endometrial receptivity, its role in embryonic development remains unclear. This study assessed the association between E2 levels on the day of human chorionic gonadotropin (hCG) trigger and the euploid blastocyst rate (EBR) in preimplantation genetic testing (PGT) cycles.  Methods: This retrospective study included 3,082 couples who underwent PGT between 2017 and 2022, comprising 18,036 oocytes and 5,009 blastocysts screened using next-generation sequencing. Oocytes were stratified into tertiles based on serum E2 levels on the hCG trigger day: Group 1 (<3149 pg/mL), Group 2 (3149–4725.66 pg/mL), and Group 3 (≥4725.67 pg/mL). Associations between serum E2 levels and both blastocyst formation rate (BFR) and EBR were assessed using univariate stratified analyses and multivariable generalized estimating equation (GEE) models (crude, Model I, Model II) accounting for patient-level clustering. Restricted cubic spline (RCS) analysis with three knots, collinearity diagnostics (variance inflation factor, VIF), and formal E2 × total gonadotropin (Gn) dose interaction tests were additionally performed.  Results: Univariate stratified analyses showed subgroup-specific patterns: higher E2 generally correlated with lower blastocyst formation rate (BFR) yet higher EBR. In fully adjusted GEE Model II, E2 was not associated with BFR (Group3 vs Group1: aOR 1.050, 95%CI 0.910–1.212, P = 0.502; P-trend=0.653), while high E2 was associated with higher EBR (aOR 1.295, 95%CI 1.028–1.631, P = 0.028; P-trend=0.047). RCS revealed no significant overall E2–BFR (P-overall=0.107; P-nonlinearity=0.055) or E2–EBR associations (P-overall=0.100; P-nonlinearity=0.119), although the EBR curve showed an upward high-E2 trend consistent with tertile results. No multicollinearity was detected (all VIF <6, range 1.137–5.399), and no significant E2–Gn interactions existed (all P>0.05). Sensitivity analysis excluding oocyte number yielded consistent EBR estimates (aOR 1.232, 95%CI 1.006–1.508, P = 0.044).  Conclusion: In PGT cycles, elevated hCG-trigger-day E2 was not associated with BFR but was modestly associated with higher EBR. These observational findings require prospective validation and should not be interpreted as evidence of a causal or protective effect of E2 on embryonic chromosomal integrity.
SN  - 1664-2392
ER  -